|
#258 Preventing Adverse Effects of Radiotherapy with CBLB502
|
N43CO900028-000
|
$149,987
|
$49,496
|
Krivokrysenko, Vadim
|
Buffalo BioLabs, LLC
|
|
Identification of Hematopoietic Stem and Progenitor Cell Viability Genes
|
1R43CA141848-01
|
$249,465
|
$249,465
|
Bonneau, Kyle
|
CELLECTA, INC.
|
|
RhoH GTPase in Hematopoiesis and Cancer
|
5R01CA113969-05
|
$318,664
|
$159,332
|
WILLIAMS, DAVID
|
CHILDREN'S HOSPITAL BOSTON
|
|
Empirical Likelihood Bayes Analysis of Quantile Regression Model
|
1R03CA133944-01A2
|
$83,120
|
$41,560
|
Kim, Mi-Ok
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA
|
5R01CA102646-05
|
$320,964
|
$160,482
|
GRUPP, STEPHAN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Determinants of Relapse Risk After BMT for ALL
|
5R01CA116660-03
|
$297,760
|
$297,760
|
GRUPP, STEPHAN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Hematopoietic Cell Transplantation for Hematologic Malignancies
|
3P01CA030206-27S1
|
$76,071
|
$76,071
|
forman, stephen
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
City of Hope Lymphoma SPORE
|
3P50CA107399-05S1
|
$1,079,832
|
$269,958
|
forman, stephen
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Hematopoietic Cell Transplantation for Hematologic Malignancies
|
5P01CA030206-27
|
$2,987,761
|
$2,987,761
|
FORMAN, STEPHEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
A Standardized Nursing Intervention Protocol for HCT Patients
|
5R01CA107446-04
|
$428,731
|
$214,366
|
GRANT, MARCIA
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
City of Hope Southwest Oncology Group Clinical Trials
|
5U10CA046368-22
|
$332,211
|
$3,322
|
MORTIMER, JOANNE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Southwest Oncology Group
|
5U10CA004919-50
|
$195,727
|
$1,957
|
BUDD, G
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Mechanisms of GVHD
|
9P01CA142106-06A1
|
$1,953,263
|
$1,953,263
|
ANTIN, JOSEPH
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S1
|
$124,531
|
$2,491
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S2
|
$100,000
|
$2,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S5
|
$143,383
|
$2,868
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-45
|
$11,688,901
|
$233,778
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Ex Vivo Alloanergization to Improve Immunity After Haploidentical Transplant
|
1R21CA137645-01A1
|
$370,550
|
$370,550
|
GUINAN, EVA
|
DANA-FARBER CANCER INSTITUTE
|
|
GM-CSF secreting tumor cell vaccines to enhance post-transplant anti-CLL immunity
|
5R21CA132232-02
|
$378,360
|
$189,180
|
WU, CATHERINE
|
DANA-FARBER CANCER INSTITUTE
|
|
Novel Approaches to Stem Cell Transplantation
|
2P01CA047741-16A1
|
$1,827,050
|
$1,187,583
|
CHAO, NELSON
|
DUKE UNIVERSITY
|
|
Novel Strategies for Cancer Immunotherapy in Stem Cell Transplant
|
1R01CA136934-01A1
|
$323,700
|
$323,700
|
YANG, YIPING
|
DUKE UNIVERSITY
|
|
Functions of E2A in B Lymphocyte Development
|
5R01CA072433-12
|
$310,291
|
$31,029
|
Zhuang, Yuan
|
DUKE UNIVERSITY
|
|
Family Decision Making in Pediatric Bone Marrow Transplant
|
5R21CA131875-02
|
$197,504
|
$197,504
|
PENTZ, REBECCA
|
EMORY UNIVERSITY
|
|
Adult Leukemia Research Center
|
5P01CA018029-34
|
$5,273,382
|
$4,429,641
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Metabolic Syndrome Following Transplant for Leukemia
|
7R01CA112530-04
|
$501,100
|
$501,100
|
BAKER, KEVIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Career Development in Pediatric and Medical Oncology
|
2K12CA076930-11
|
$595,080
|
$196,376
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Pediaric Oncology Research Training Program
|
5T32CA009351-31
|
$223,195
|
$89,278
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Southwest Oncology Group Statistical Center
|
5U10CA038926-24
|
$4,746,162
|
$47,462
|
CROWLEY, JOHN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Immunosupression-Resistant Gene Modified Donor T Cells
|
5R01CA109381-05
|
$323,970
|
$323,970
|
GEORGES, GEORGE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
2P30CA015704-35
|
$10,977,925
|
$1,207,572
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-35S3
|
$249,999
|
$27,500
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-35S4
|
$85,601
|
$9,416
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-35S5
|
$100,000
|
$11,000
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Clinical Significance of MHC Haplotypes in HCT
|
5R01CA100019-07
|
$344,520
|
$344,520
|
Petersdorf, Effie
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Therapy of Lymphoma/Leukemia with Monoclonal Antibodies
|
5P01CA044991-22
|
$2,026,942
|
$608,083
|
Press, Oliver
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Targeted therapy of ALL with gene-modified central memory T cells
|
1R01CA136551-01A1
|
$551,563
|
$275,782
|
Riddell, Stanley
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Mixed Hematopoietic Chimerism After Stem Cell Allografts
|
2P01CA078902-11
|
$1,991,605
|
$1,832,277
|
STORB, RAINER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Genetic Predictors of Cognitive Function, Depression and Fatigue in Cancer
|
1K07CA138499-01A1
|
$146,115
|
$146,115
|
Jim, Heather
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
The Significance of MARCO Expression by Tumor-Pulsed Dendritic Cells
|
5R01CA071669-11
|
$374,438
|
$374,438
|
MULE, JAMES
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Stem cell manipulation via HOX gene regulation
|
5R01CA090833-08
|
$280,779
|
$140,390
|
EMERSON, STEPHEN
|
HAVERFORD COLLEGE
|
|
Towards a Mouse Model of Classical Hodgkin's Disease and PTLD
|
2R01CA098285-06A1
|
$487,828
|
$243,914
|
RAJEWSKY, KLAUS
|
IMMUNE DISEASE INSTITUTE, INC.
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
3P30CA082709-11S1
|
$113,669
|
$3,410
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
3P30CA082709-11S2
|
$49,258
|
$1,478
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
5P30CA082709-11
|
$1,302,544
|
$39,076
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Durable CD4+ T-cell Tumor Immunity Following Gene-modified HPSC
|
1R01CA134014-01A2
|
$300,018
|
$300,018
|
Touloukian, Christopher
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
The role of myeloid suppressor cells in tumor-specific tolerance
|
5R01CA124996-03
|
$336,036
|
$110,892
|
BORRELLO, IVAN
|
JOHNS HOPKINS UNIVERSITY
|
|
Marrow Infiltrating Lymphocyte Immunotherapy in Myeloma
|
5R21CA130344-02
|
$369,000
|
$369,000
|
BORRELLO, IVAN
|
JOHNS HOPKINS UNIVERSITY
|
|
Restoring T Cell Responses to Therapeutic Tumor Vaccines
|
5R01CA105148-05
|
$318,780
|
$318,780
|
FUCHS, EPHRAIM
|
JOHNS HOPKINS UNIVERSITY
|
|
Bone Marrow Transplantation in Human Disease
|
5P01CA015396-34
|
$3,012,562
|
$3,012,562
|
JONES, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
|
Augmenting Antitumor Immunity after Allografting
|
5R01CA122779-02
|
$291,285
|
$291,285
|
LUZNIK, LEO
|
JOHNS HOPKINS UNIVERSITY
|
Total relevant funding to Bone Marrow Transplantation for this search: $60,626,760
|